22nd Century Group (NYSE:XXII) Upgraded by StockNews.com to Sell

22nd Century Group (NYSE:XXIIGet Rating) was upgraded by StockNews.com to a “sell” rating in a report issued on Thursday.

Shares of NYSE:XXII traded up $0.17 during trading on Thursday, reaching $1.98. The stock had a trading volume of 1,330,800 shares, compared to its average volume of 1,817,015. 22nd Century Group has a fifty-two week low of $1.42 and a fifty-two week high of $5.25.

About 22nd Century Group (Get Rating)

22nd Century Group, Inc, an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies.

See Also

Want More Great Investing Ideas?

Receive News & Ratings for 22nd Century Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 22nd Century Group and related companies with MarketBeat.com's FREE daily email newsletter.